Billecke SS, Primo-Parmo SL, Dunlop CS, Doorn JA, La Du BN, Broomfield CA (1999) <br />Characterization of a soluble mouse liver enzyme capable of hydrolyzing diisopropyl phosphorofluoridate<br /><i>Chemico-Biological Interactions</i> <b>119-120</b>: 251<br /><br />Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) <br />Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase<br /><i>J Clinical Investigation</i> <b>101</b>: 1581<br /><br />Primo-Parmo SL, Lightstone H, La Du BN (1997) <br />Characterization of an unstable variant (BChE115D) of human butyrylcholinesterase<br /><i>Pharmacogenetics</i> <b>7</b>: 27<br /><br />Primo-Parmo SL, Bartels CF, Wiersema B, van der Spek AF, Innis JW, La Du BN (1996) <br />Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene<br /><i>American Journal of Human Genetics</i> <b>58</b>: 52<br /><br />Primo-Parmo SL, Sorenson RC, Teiber JF, La Du BN (1996) <br />The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family<br /><i>Genomics</i> <b>33</b>: 498<br /><br />Greenberg CP, Primo-Parmo SL, Pantuck EJ, La Du BN (1995) <br />Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods<br /><i>Anesthesia & Analgesia</i> <b>81</b>: 419<br /><br />Sorenson RC, Primo-Parmo SL, Kuo CL, Adkins S, Lockridge O, La Du BN (1995) <br />Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase<br /><i>Proc Natl Acad Sci U S A</i> <b>92</b>: 7187<br /><br />Picheth G, Fadel-Picheth C, Primo-Parmo SL, Chautard-Freire-Maia EA, Vieira MM (1994) <br />An improved method for butyrylcholinesterase phenotyping [published erratum appears in Biochem Genet 1994 Oct;32(9-10):379]<br /><i>Biochemical Genetics</i> <b>32</b>: 83<br /><br />Hidaka K, Iuchi I, Yamasaki T, Ohhara M, Shoda T, Primo-Parmo SL, La Du BN (1992) <br />[Identification of two different genetic mutation associated with silent phenotypes for human serum cholinesterase in Japanese]<br /><i>Rinsho Byori</i> <b>40</b>: 535<br /><br />Primo-Parmo SL, Bartels CF (1992) <br />Heterogeneity of the Silent Phenotype of Human Butyrylcholinesterase - Identification of Eight New Mutations<br /><i>In Multidisciplinary approaches to cholinesterase functions - Proceedings of Fourth International Meeting on Cholinesterases</i> <b>(Shafferman, A. and Velan, B., Eds) Plenum Press, New York</b>: 61<br /><br />Chautard-Freire-Maia EA, Primo-Parmo SL, Picheth G, Lourenco MA, Vieira MM (1991) <br />The C5 isozyme of serum cholinesterase and adult weight<br /><i>Hum Hered</i> <b>41</b>: 330<br /><br />Chautard-Freire-Maia EA, Primo-Parmo SL, Canever de Lourenco MA, Culpi L (1984) <br />Frequencies of atypical serum cholinesterase among Caucasians and Negroes from southern Brazil<br /><i>Hum Hered</i> <b>34</b>: 388<br /><br />Primo-Parmo SL, Chautard-Freire-Maia EA (1982) <br />Absence of linkage between the serum cholinesterase (CHE1) and rhesus (RH) loci<br /><i>Hum Genet</i> <b>60</b>: 284<br /><br />